On Wednesday, Genetic Technologies Limited (ADR) (NASDAQ:GENE)’s shares inclined 37.91% to $2.91.
GENE offered 37.80% EPS for prior five years. The company has -268.60% return on equity value while its ROI ratio was -46.70%. The company has $24.50 billion market capitalizations and the institutional ownership was 37.80%. Its price to book ratio was 2.05. Volatility of the stock was 22.24% for the week while for the month booked as 9.56%.
The mean estimate for the short term price target for Genetic Technologies Limited (ADR) (NASDAQ:GENE) stands at $12.50 according to 1 Analysts. The higher price target estimate for the stock has been calculated at $12.50 while the lower price target estimate is at $12.50.
Analysts mean recommendation for the stock is 3.00. This number is based on a 1 to 5 scale where 1 indicates a Strong Buy recommendation while 5 represents a Strong Sell.
Genetic Technologies Limited is a molecular diagnostics company. The Company offers predictive testing and assessment tools to assist physicians manage women’s health.
UnitedHealth Group Inc (NYSE:UNH)’s shares dropped -2.58% to $114.63.
UNH has beta value of 0.56. The company has the market capitalization of $112.19 billion. Return on assets ratio of the company was 6.50% while its return on equity ratio was 18.70%. ATR value of company was 3.36 while stock volatility for week was 2.19% while for month was 2.91%. Debt to equity ratio of the company was -0.96.
The mean estimate for the short term price target for UnitedHealth Group Inc (NYSE:UNH) stands at $146.45 according to 22 Analysts. The higher price target estimate for the stock has been calculated at $172.00 while the lower price target estimate is at $133.00.
Analysts mean recommendation for the stock is 1.70. This number is based on a 1 to 5 scale where 1 indicates a Strong Buy recommendation while 5 represents a Strong Sell.
UnitedHealth Group Incorporated is a health and well-being company. The Company’s business platforms comprise UnitedHealthcare and Optum. UnitedHealthcare provides health care benefits to various customers and markets.
At the end of Wednesday’s trade, Brookdale Senior Living, Inc. (NYSE:BKD)‘s shares surged 0.09% to $22.33.
BKD is currently valued at $4.12 billion. The company has 184.52 million shares outstanding. The company has 0.85 value in price to sale ratio while price to book ratio was recorded as 1.53. The company exchanged hands with 4.56 million shares as compared to its average daily volume of 5.00 million shares. It beta stands at 2.17.
The mean estimate for the short term price target for Brookdale Senior Living, Inc. (NYSE:BKD) stands at $35.75 according to 8 Analysts. The higher price target estimate for the stock has been calculated at $40.00 while the lower price target estimate is at $25.00.
Analysts mean recommendation for the stock is 1.90. This number is based on a 1 to 5 scale where 1 indicates a Strong Buy recommendation while 5 represents a Strong Sell.
Brookdale Senior Living Inc. operates senior living communities in the United States. The Company operates independent, assisted living and dementia-care communities, and ongoing care retirement centers (CCRCs).
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.